The Heritage At Lowman Rehab And Healthcare Medicare and Medicaid Location: 201 Fortress Drive, White Rock, South Carolina 29177 Ratings: Phone: (803) 732-3000 |
News Archive
Relypsa, Inc., today announced the initiation of patient enrollment in a Phase 2, open-label titration clinical study of the company's lead drug candidate, RLY5016, in heart failure patients with chronic kidney disease. RLY5016 is a novel non-absorbed oral potassium binder intended to prevent and treat hyperkalemia, a serious condition characterized by elevated serum potassium levels.
What did all the following businessmen have in common?
The U.S. Supreme Court is expected to rule shortly on whether generic drug companies must adequately warn doctors about new or revised risks to patients who have taken the drugs they make. (Pliva v Mensing No. 09-993, Actavis v Mensing No.08-3850 and Actavis v Demahy No. 09-1501) All three cases involve patients who took metoclopramide, the generic version of the brand-name drug Reglan.
A new study by thoracic surgeons and pathologists at Memorial Sloan-Kettering Cancer Center shows that a specific pattern found in the tumor pathology of some lung cancer patients is a strong predictor of recurrence.
Medicomp Systems newest documentation and patient management application, Quippe, has been imbedded into MED3OOO's InteGreat EHR. Quippe is an easy to use and learn interface that puts the power to care back into the hands of the clinicians and allows them to focus on the patient, not data entry.
› Verified 8 days ago